Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
BOSTON and ATHENS, Ga., June 03, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced the appointment of Lynn Swann to its Board of Directors.
- BOSTON and ATHENS, Ga., June 03, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced the appointment of Lynn Swann to its Board of Directors.
- “It is a pleasure to welcome Lynn, a former NFL player, Hall of Famer, broadcaster, politician and athletic director, to our Board of Directors,” said Bill Griffin, Chairman of the Board at Aruna Bio.
- Having witnessed concussions on the football field firsthand, I am delighted to contribute to the process of finding solutions for neurodegenerative conditions.
- Mr. Swann currently serves on the Board of Directors of Athene Holding Ltd. (ATH), Apollo Global Management (AGM) and American Homes 4 Rent (AMH), a leading large-scale owner and developer of single-family rental homes.